Chinese Journal of Pharmaceuticals
|
2025, 56(12): 1583-1590
• Pharmaceutical Management & Information •
Regulatory Practices and Implications of Applying Artificial Intelligence in the Field of Drug Development Abroad
Full
Shang CAO, Wenyan XU, Yi FAN*
Affiliations
- Yangtze River Delta Center for Drug Evaluation and Inspection of NMPA, Shanghai 200120
Published: 2025-12-10
doi: 10.16522/j.cnki.cjph.2025.12.013
Outline
曹尚, 许文艳, 范乙.
国外药物研发领域应用人工智能的监管实践及启示.
中国医药工业杂志,
2025
, 56
(12)
: 1583
-1590
.
DOI: 10.16522/j.cnki.cjph.2025.12.013
Shang CAO, Wenyan XU, Yi FAN.
Regulatory Practices and Implications of Applying Artificial Intelligence in the Field of Drug Development Abroad[J].
Chinese Journal of Pharmaceuticals,
2025
, 56
(12)
: 1583
-1590
.
DOI: 10.16522/j.cnki.cjph.2025.12.013
Year 2025 volume 56 Issue 12
29
9
Cite this Article
BibTeX
Article Info
doi: 10.16522/j.cnki.cjph.2025.12.013
- Receive Date:2025-05-17
- Online Date:2026-11-18
- Published:2025-12-10